What's in Delenex Therapeutics AG's pipeline?

Delenex Therapeutics AG has 2 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with Delenex Therapeutics AG's portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Ain Shams University, Aligarh Muslim University, Atlantic Health System, Aultman Health Foundation.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/delenex-therapeutics-ag.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Delenex Therapeutics AG — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delenex Therapeutics AG pipeline: 0 marketed, 0 filed, 0 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Ain Shams University · 1 shared drug class
Aligarh Muslim University · 1 shared drug class
Atlantic Health System · 1 shared drug class
Aultman Health Foundation · 1 shared drug class
B.P. Koirala Institute of Health Sciences · 1 shared drug class
Bagcilar Training and Research Hospital · 1 shared drug class
Abant Izzet Baysal University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Delenex Therapeutics AG:

Cite this brief

Drug Landscape (2026). Delenex Therapeutics AG — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/delenex-therapeutics-ag. Accessed 2026-05-17.